News Releases

Nov 08, 2019
Sangamo Therapeutics Announces New Scientific Advisory Board
Members include distinguished international experts across a diverse range of scientific and therapeutic areas BRISBANE, Calif. --(BUSINESS WIRE)--Nov. 8, 2019-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that is has established a new Scientific Advisory
Additional Formats
PDF Version
Nov 06, 2019
Sangamo Therapeutics Reports Third Quarter 2019 Financial Results
Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time BRISBANE, Calif. --(BUSINESS WIRE)--Nov. 6, 2019-- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported third quarter 2019 financial results and recent business highlights.
Additional Formats
PDF Version
Displaying 1 - 10 of 43